Description: Hera has full coverage on licensed technologies and is the first toxicology CRO focused on providing better predictability and sensitivity through genome editing technologies.
services (28209) tools (5065) pharmaceutical (1236) laboratory (1100) cro (469) toxicology (127) gene editing (23) predictability (9) transposagen (2) licensed technologies (2)
Sorry, this product is unavailable. Please choose a different combination.
Whether your focus is on xenograft/PDX drug efficacy studies, gene editing, or research model creation, our team can advance your drug development efforts.
Hera BioLabs is a full-service CRO, offering a broad range of in vivo studies in both mouse and rat models. With our state-of-the-art facility, we can complete your in vivo efficacy tumor xenograft or PDX model study in your preferred mouse model or our proprietary SRG OncoRat®.